Autoantibodies against myelin oligodendrocyte glycoprotein in a subgroup of patients with psychotic symptoms

Autoantibodies against myelin oligodendrocyte glycoprotein in a subgroup of patients with psychotic symptoms

The presence of autoantibodies against myelin oligodendrocyte glycoprotein (MOG) is a hallmark of MOG antibody-associated disease (MOGAD), a recently defined demyelinating disease entity presenting with core clinical features of optic neuritis, myelitis, and acute disseminated encephalomyelitis. Alt...

Full description

Saved in:
Bibliographic Details
Main Authors: Nikita A. van de Burgt, Laila Kulsvehagen, Marina Mané-Damas, Luc Lutz, Anne-Catherine Lecourt, Clara Monserrat, Anita M. Vinke, Cem İ. Küçükali, Shenghua Zong, Carolin Hoffmann, Emiliano González-Vioque, Celso Arango, Nicole K. Leibold, Mario Losen, Peter C. Molenaar, Erdem Tüzün, Nico J. M. van Beveren, Anna Mané, Rob P. W. Rouhl, Therese A. M. J. van Amelsvoort, for Genetic Risk and Outcome of Psychosis (GROUP) Investigators, Anne-Katrin Pröbstel, Pilar Martinez-Martinez
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Neurology
Subjects:
myelin oligodendrocyte glycoprotein antibody-associated disease
autoantibodies
neuroinflammation
psychiatry
mental disorders
psychosis
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2025.1593042/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2025.1593042/full

Similar Items